ClinicalTrials.gov
public full text
Public Domain
Calcium and Magnesium Infusion for the Prevention of Taxane Induced Neuropathy
This is a pilot study evaluating the feasibility of intravenous calcium and magnesium (Ca/Mg) infusion for prevention of taxane induced neuropathy in patients with early stage breast cancer receiving adjuvant or neo-adjuvant paclitaxel, either given every 2 weeks for 4 cycles or every week for 12 weeks.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Web-Based Exercise for Neuropathy and Quality of Life in Breast Cancer#869858
- Fingolimod in Preventing Paclitaxel-Associated Neuropathy in Patients With Breast Cancer#1308292
- Effect of Exercise in the Management of Peripheral Neuropathy#879292
- GM1 Prophylaxis for Nab-paclitaxel-associated Chemotherapy-induced Peripheral Neuropathy (CIPN) in Patients With Breast Cancer#844370
- Testing the Effects of Exercise on Chemotherapy-Induced Peripheral Neuropathy#311050
Record · ID 1183411
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive